Zeyuan Fan

Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

The triglyceride-glucose index shows a stronger association with complex coronary artery disease than the ACEF score among young and middle-aged adults with aortic valve calcification.

The triglyceride-glucose index shows a stronger association with complex coronary artery disease than the ACEF score among young and middle-aged adults with aortic valve calcification.

Journal: Frontiers in cardiovascular medicine

Published: November 25, 2025

Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention: 1-Year Results From the RIGHT Trial and Meta-analyses.

Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention: 1-Year Results From the RIGHT Trial and Meta-analyses.

Journal: JACC. Asia

Published: November 13, 2025

Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Stage 4 Cardiovascular-Kidney-Metabolic Syndrome: A Propensity Score-Matched Study.

Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Stage 4 Cardiovascular-Kidney-Metabolic Syndrome: A Propensity Score-Matched Study.

Journal: Journal of the American Heart Association

Published: August 12, 2025

Correlation between pharmacologic blood pressure-lowering intensity and improvement in cardiac function in patients with acutely decompensated heart failure.

Correlation between pharmacologic blood pressure-lowering intensity and improvement in cardiac function in patients with acutely decompensated heart failure.

Journal: BMC cardiovascular disorders

Published: August 02, 2025

Combination of treatment intensity score and interankle diastolic blood pressure is associated with cardiovascular prognosis among adults with controlled hypertension who have pre-existing cardiovascular disease.

Combination of treatment intensity score and interankle diastolic blood pressure is associated with cardiovascular prognosis among adults with controlled hypertension who have pre-existing cardiovascular disease.

Journal: Blood pressure monitoring

Published: June 25, 2025

Reply to the letter to the editor on the combination treatment of SGLT2i and GLP-1RA associated with improved cardiovascular outcomes in T2D with ACS.

Reply to the letter to the editor on the combination treatment of SGLT2i and GLP-1RA associated with improved cardiovascular outcomes in T2D with ACS.

Journal: International journal of cardiology

Published: May 04, 2025

Dose-related efficacy and safety of sodium tanshinone II A sulfonate for the treatment of unstable angina pectoris: a meta-analysis.

Dose-related efficacy and safety of sodium tanshinone II A sulfonate for the treatment of unstable angina pectoris: a meta-analysis.

Journal: Minerva cardiology and angiology

Published: March 07, 2025

Combination treatment of SGLT2i and GLP-1RA associated with improved cardiovascular outcomes in type 2 diabetes patients with acute coronary syndrome: A propensity score-matched cohort study.

Combination treatment of SGLT2i and GLP-1RA associated with improved cardiovascular outcomes in type 2 diabetes patients with acute coronary syndrome: A propensity score-matched cohort study.

Journal: International journal of cardiology

Published: February 08, 2025

Percutaneous coronary intervention vs . medical therapy in patients on dialysis with coronary artery disease in China.

Percutaneous coronary intervention vs . medical therapy in patients on dialysis with coronary artery disease in China.

Journal: Chinese medical journal

Published: June 07, 2024

Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial.

Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial.

Journal: Circulation

Published: February 26, 2024

Association of sodium-glucose cotransporter 2 inhibitors with risk of major adverse cardiovascular events in type 2 diabetes patients with acute coronary syndrome: a propensity score‑matched analysis.

Association of sodium-glucose cotransporter 2 inhibitors with risk of major adverse cardiovascular events in type 2 diabetes patients with acute coronary syndrome: a propensity score‑matched analysis.

Journal: Cardiovascular diabetology

Published: February 15, 2024

The Association between Dapagliflozin Use and the Risk of Post-Contrast Acute Kidney Injury in Patients with Type 2 Diabetes and Chronic Kidney Disease: A Propensity-Matched Analysis.

The Association between Dapagliflozin Use and the Risk of Post-Contrast Acute Kidney Injury in Patients with Type 2 Diabetes and Chronic Kidney Disease: A Propensity-Matched Analysis.

Journal: Kidney & blood pressure research

Published: June 04, 2023

Showing 1-12 of 20

Last Updated: 09/26/2026